USE OF NASAL TRANSCRIPTOMICS TO STUDY CHANGES WITH LUMACAFTOR-IVACAFTOR AND THE PRESENCE OF THE IONOCYTE

被引：0
|
作者：
Sala, M. A. [1 ]
Khuder, B. [1 ]
Nicholson, T. [2 ,3 ]
McKone, E. [2 ,3 ]
Reyfman, P. A. [1 ]
Jain, M. [1 ]
机构：
[1] Northwestern Univ, Pulm & Crit Care Med, Chicago Campus, Chicago, IL 60611 USA
[2] St Vincents Univ Hosp, Dublin, Ireland
[3] Univ Coll Dublin, Dublin, Ireland
来源：
PEDIATRIC PULMONOLOGY | 2020年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
39
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 16 条
  • [1] Real-life Study confirms Effectiveness of Lumacaftor-Ivacaftor
    Krome, Susanne
    [J]. PNEUMOLOGIE, 2020, 74 (04):
  • [2] UPTAKE OF LUMACAFTOR-IVACAFTOR USE AMONG ELIGIBLE CF PATIENTS IN THE US IN 2015
    Sawicki, G. S.
    Fink, A.
    Hamblett, N. M.
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 : 382 - 382
  • [3] Real-world study finds higher discontinuation rates for lumacaftor-ivacaftor than previously reported
    Clough, Isobel
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (11) : 634 - 634
  • [4] RETROSPECTIVE REVIEW OF PROTON PUMP INHIBITOR USE IN CYSTIC FIBROSIS PATIENTS INITIATING LUMACAFTOR-IVACAFTOR (ORKAMBI) TREATMENT
    Roth, K.
    Novak, K. J.
    [J]. PEDIATRIC PULMONOLOGY, 2017, 52 : S457 - S457
  • [5] Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-study
    Donaldson, Scott H.
    Laube, Beth L.
    Mogayzel, Peter
    Corcoran, Timothy E.
    Pilewski, Joseph M.
    Ceppe, Agathe
    Wu, Jihong
    Bhambhvani, Pradeep G.
    Ratjen, Felix
    Sagel, Scott D.
    Clancy, J. P.
    Rowe, Steven M.
    Bennett, William D.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : 143 - 145
  • [6] LUMACAFTOR-IVACAFTOR TOLERANCE IN CYSTIC FIBROSIS PATIENTS HOMOZYGOUS FOR PHE508DEL CFTR: A SINGLE-CENTER OBSERVATIONAL STUDY
    Taylor, T.
    Brown, R. F.
    Tolle, J.
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 : 292 - 292
  • [7] SUSTAINED ANTI-INFLAMMATORY EFFECTS OF LUMACAFTOR-IVACAFTOR IN SPUTUM AND PERIPHERAL BLOOD SAMPLES OF ADULT CYSTIC FIBROSIS PATIENTS- AN OBSERVATIONAL STUDY
    Arooj, P.
    Morrissy, D.
    Ronan, N.
    McCarthy, Y.
    Fleming, C.
    Eustace, J. A.
    Murphy, D. M.
    Plant, B. J.
    [J]. THORAX, 2022, 77 : A20 - A21
  • [8] ROCK STUDY in CF: sustained anti-inflammatory effects of lumacaftor-ivacaftor in sputum and peripheral blood samples of adult patients with cystic fibrosis-an observational study
    Arooj, Parniya
    Morrissy, David V.
    McCarthy, Yvonne
    Vagg, Tamara
    McCarthy, Mairead
    Fleming, Claire
    Daly, Mary
    Eustace, Joseph A.
    Murphy, Desmond M.
    Plant, B. J.
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [9] Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study
    Shaw, Michelle
    Khan, Umer
    Clancy, John P.
    Donaldson, Scott H.
    Sagel, Scott D.
    Rowe, Steven M.
    Ratjen, Felix
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (06) : 931 - 933
  • [10] CHANGES IN LCI IN F508DEL/F508DEL PATIENTS TREATED WITH LUMACAFTOR/IVACAFTOR: RESULTS FROM THE PROSPECT STUDY
    Ratjen, F.
    Klingel, M.
    Clancy, J. P.
    Sagel, S.
    Donaldson, S. H.
    Rowe, S. M.
    [J]. PEDIATRIC PULMONOLOGY, 2017, 52 : S287 - S287
12